An update on chemical eye burns
M Bizrah, A Yusuf, S Ahmad - Eye, 2019 - nature.com
Ocular chemical injuries vary in severity, with the more severe end of the spectrum having
profound visual consequences and medicolegal implications. Grading of ocular injuries is …
profound visual consequences and medicolegal implications. Grading of ocular injuries is …
Cystoid macular edema related to cataract surgery and topical prostaglandin analogs: mechanism, diagnosis, and management
G Holló, T Aung, LB Cantor, M Aihara - Survey of Ophthalmology, 2020 - Elsevier
Cystoid macular edema (CME) is a form of macular retina thickening that is characterized by
the appearance of cystic fluid-filled intraretinal spaces. It has classically been diagnosed …
the appearance of cystic fluid-filled intraretinal spaces. It has classically been diagnosed …
Cataract in the Adult Eye Preferred Practice Pattern®
KM Miller, TA Oetting, JP Tweeten, K Carter, BS Lee… - Ophthalmology, 2022 - Elsevier
Evidence-based update of the Cataract in the Adult Eye Preferred Practice Pattern®(PPP)
guidelines, describing the prevalence, risk factors, and natural history of cataract …
guidelines, describing the prevalence, risk factors, and natural history of cataract …
European multicenter trial of the prevention of cystoid macular edema after cataract surgery in nondiabetics: ESCRS PREMED study report 1
LHP Wielders, JSAG Schouten, B Winkens… - Journal of Cataract & …, 2018 - Elsevier
Purpose To compare the efficacy of a topical nonsteroidal antiinflammatory drug, topical
corticosteroid, and a combination of both drugs to prevent the occurrence of cystoid macular …
corticosteroid, and a combination of both drugs to prevent the occurrence of cystoid macular …
Recent advances in the design of topical ophthalmic delivery systems in the treatment of ocular surface inflammation and their biopharmaceutical evaluation
R Mazet, JBG Yaméogo, D Wouessidjewe… - Pharmaceutics, 2020 - mdpi.com
Ocular inflammation is one of the most common symptom of eye disorders and diseases.
The therapeutic management of this inflammation must be rapid and effective in order to …
The therapeutic management of this inflammation must be rapid and effective in order to …
NSAID-induced corneal melt: Clinical importance, pathogenesis, and risk mitigation
B Rigas, W Huang, R Honkanen - Survey of ophthalmology, 2020 - Elsevier
Corneal melt, an ophthalmological condition in which corneal epithelium is lost
accompanied by thinning of the corneal stroma, can lead to corneal perforation and cause …
accompanied by thinning of the corneal stroma, can lead to corneal perforation and cause …
Optimization of hyaluronan-enriched cubosomes for bromfenac delivery enhancing corneal permeation: characterization, ex vivo, and in vivo evaluation
To design and evaluate hyaluronan-based cubosomes loaded with bromfenac sodium (BS)
for ocular application to enhance the corneal permeation and retention in pterygium and …
for ocular application to enhance the corneal permeation and retention in pterygium and …
Dual drug delivery from hydrophobic and hydrophilic intraocular lenses: in-vitro and in-vivo studies
A Topete, J Tang, X Ding, HP Filipe, JA Saraiva… - Journal of Controlled …, 2020 - Elsevier
Posterior capsule opacification (PCO) still remains the most frequent long term complication
after cataract surgery, while endophthalmitis is rare but severe and should be prevented at …
after cataract surgery, while endophthalmitis is rare but severe and should be prevented at …
Nanomedicine for the effective and safe delivery of non-steroidal anti-inflammatory drugs: A review of preclinical research
The toxicity of nonsteroidal anti-inflammatory drugs (NSAIDs) is one of the major limitations
to their long-term use in the treatment of chronic inflammatory conditions. This review …
to their long-term use in the treatment of chronic inflammatory conditions. This review …
Dexamethasone intracanalicular insert: a review in treating post-surgical ocular pain and inflammation
A Lee, HA Blair - Drugs, 2020 - Springer
Dextenza®, an intracanalicular insert that is placed into the lower punctal opening of the
eye, gradually releases dexamethasone for up to 30 days to alleviate pain and inflammation …
eye, gradually releases dexamethasone for up to 30 days to alleviate pain and inflammation …